Global Morphine Market Insights, Forecast to 2025

Publisher Name :
Date: 19-Dec-2018
No. of pages: 113
Inquire Before Buying

Morphine is a pain medication of the opiate family which is found naturally in a number of plants and animals.

As per the International Narcotics Control Board, 92 % of the worlds morphine is consumed by 17% of the worlds population, while the rest of the world population consumes around 8% of morphine.

The growth of the market for is driven by factors such as lifestyle changes that lead to pain and growth in number of surgical procedures as the drug is prescribed for pain relief post-surgery.

However, the addictive nature of the drug restricts the growth of the global morphine market.

The global Morphine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Morphine market based on company, product type, end user and key regions.

This report studies the global market size of Morphine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Morphine in these regions.

This research report categorizes the global Morphine market by top players/brands, region, type and end user. This report also studies the global Morphine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Mallinckrodt Pharmaceuticals

- Alcaliber

- Purdue Pharma

- Sanofi Winthrop Industrie

- Macfarlan Smith

- Sun Pharmaceutical Industries

- Qinghai Pharmaceutical

- Northeast Pharmaceutical Group

Market size by Product

- Oral Tablets

- Injection

- Capsule

- Others

Market size by End User

- Anesthesia

- Cough Suppressant

- Diarrhea Suppressant

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Morphine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Morphine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Morphine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Morphine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Morphine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Morphine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Morphine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Morphine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Morphine Market Size Growth Rate by Product
1.4.2 Oral Tablets
1.4.3 Injection
1.4.4 Capsule
1.4.5 Others
1.5 Market by End User
1.5.1 Global Morphine Market Size Growth Rate by End User
1.5.2 Anesthesia
1.5.3 Cough Suppressant
1.5.4 Diarrhea Suppressant
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Morphine Market Size
2.1.1 Global Morphine Revenue 2014-2025
2.1.2 Global Morphine Sales 2014-2025
2.2 Morphine Growth Rate by Regions
2.2.1 Global Morphine Sales by Regions
2.2.2 Global Morphine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Morphine Sales by Manufacturers
3.1.1 Morphine Sales by Manufacturers
3.1.2 Morphine Sales Market Share by Manufacturers
3.1.3 Global Morphine Market Concentration Ratio (CR5 and HHI)
3.2 Morphine Revenue by Manufacturers
3.2.1 Morphine Revenue by Manufacturers (2014-2019)
3.2.2 Morphine Revenue Share by Manufacturers (2014-2019)
3.3 Morphine Price by Manufacturers
3.4 Morphine Manufacturing Base Distribution, Product Types
3.4.1 Morphine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Morphine Product Type
3.4.3 Date of International Manufacturers Enter into Morphine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Morphine Sales by Product
4.2 Global Morphine Revenue by Product
4.3 Morphine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Morphine Breakdown Data by End User
6 North America
6.1 North America Morphine by Countries
6.1.1 North America Morphine Sales by Countries
6.1.2 North America Morphine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Morphine by Product
6.3 North America Morphine by End User
7 Europe
7.1 Europe Morphine by Countries
7.1.1 Europe Morphine Sales by Countries
7.1.2 Europe Morphine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Morphine by Product
7.3 Europe Morphine by End User
8 Asia Pacific
8.1 Asia Pacific Morphine by Countries
8.1.1 Asia Pacific Morphine Sales by Countries
8.1.2 Asia Pacific Morphine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Morphine by Product
8.3 Asia Pacific Morphine by End User
9 Central & South America
9.1 Central & South America Morphine by Countries
9.1.1 Central & South America Morphine Sales by Countries
9.1.2 Central & South America Morphine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Morphine by Product
9.3 Central & South America Morphine by End User
10 Middle East and Africa
10.1 Middle East and Africa Morphine by Countries
10.1.1 Middle East and Africa Morphine Sales by Countries
10.1.2 Middle East and Africa Morphine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Morphine by Product
10.3 Middle East and Africa Morphine by End User
11 Company Profiles
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Mallinckrodt Pharmaceuticals Morphine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Mallinckrodt Pharmaceuticals Morphine Products Offered
11.1.5 Mallinckrodt Pharmaceuticals Recent Development
11.2 Alcaliber
11.2.1 Alcaliber Company Details
11.2.2 Company Business Overview
11.2.3 Alcaliber Morphine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Alcaliber Morphine Products Offered
11.2.5 Alcaliber Recent Development
11.3 Purdue Pharma
11.3.1 Purdue Pharma Company Details
11.3.2 Company Business Overview
11.3.Purdue Pharma Morphine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Purdue Pharma Morphine Products Offered
11.3.5 Purdue Pharma Recent Development
11.4 Sanofi Winthrop Industrie
11.4.1 Sanofi Winthrop Industrie Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Winthrop Industrie Morphine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Winthrop Industrie Morphine Products Offered
11.4.5 Sanofi Winthrop Industrie Recent Development
11.5 Macfarlan Smith
11.5.1 Macfarlan Smith Company Details
11.5.2 Company Business Overview
11.5.3 Macfarlan Smith Morphine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Macfarlan Smith Morphine Products Offered
11.5.5 Macfarlan Smith Recent Development
11.6 Sun Pharmaceutical Industries
11.6.1 Sun Pharmaceutical Industries Company Details
11.6.2 Company Business Overview
11.6.3 Sun Pharmaceutical Industries Morphine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Sun Pharmaceutical Industries Morphine Products Offered
11.6.5 Sun Pharmaceutical Industries Recent Development
11.7 Qinghai Pharmaceutical
11.7.1 Qinghai Pharmaceutical Company Details
11.7.2 Company Business Overview
11.7.3 Qinghai Pharmaceutical Morphine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Qinghai Pharmaceutical Morphine Products Offered
11.7.5 Qinghai Pharmaceutical Recent Development
11.8 Northeast Pharmaceutical Group
11.8.1 Northeast Pharmaceutical Group Company Details
11.8.2 Company Business Overview
11.8.3 Northeast Pharmaceutical Group Morphine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Northeast Pharmaceutical Group Morphine Products Offered
11.8.5 Northeast Pharmaceutical Group Recent Development
12 Future Forecast
12.1 Morphine Market Forecast by Regions
12.1.1 Global Morphine Sales Forecast by Regions 2019-2025
12.1.2 Global Morphine Revenue Forecast by Regions 2019-2025
12.2 Morphine Market Forecast by Product
12.2.1 Global Morphine Sales Forecast by Product 2019-2025
12.2.2 Global Morphine Revenue Forecast by Product 2019-2025
12.3 Morphine Market Forecast by End User
12.4 North America Morphine Forecast
12.5 Europe Morphine Forecast
12.6 Asia Pacific Morphine Forecast
12.7 Central & South America Morphine Forecast
12.8 Middle East and Africa Morphine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Morphine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Morphine Product Picture
Table Morphine Market Segments
Table Key Manufacturers Morphine Covered
Table Global Morphine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Morphine Sales Market Share by Product 2014-2025
Figure Oral Tablets Product Picture
Table Major Manufacturers of Oral Tablets
Figure Injection Product Picture
Table Major Manufacturers of Injection
Figure Capsule Product Picture
Table Major Manufacturers of Capsule
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Morphine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Anesthesia
Figure Cough Suppressant
Figure Diarrhea Suppressant
Figure Morphine Report Years Considered
Figure Global Morphine Market Size 2014-2025 (Million US$)
Figure Global Morphine Sales 2014-2025 (K Units)
Table Global Morphine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Morphine Sales by Regions 2014-2019 (K Units)
Table Global Morphine Sales Market Share by Regions 2014-2019
Figure Global Morphine Sales Market Share by Regions 2014-2019
Figure 2018 Global Morphine Sales Market Share by Regions
Table Global Morphine Revenue by Regions 2014-2019 (Million US$)
Table Global Morphine Revenue Market Share by Regions 2014-2019
Figure Global Morphine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Morphine Revenue Market Share by Regions
Table Global Morphine Sales by Manufacturers (2014-2019) (K Units)
Table Global Morphine Sales Share by Manufacturers (2014-2019)
Figure Global Morphine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Morphine Revenue by Manufacturers (2014-2019) (Million USD)
Table Morphine Revenue Share by Manufacturers (2014-2019)
Figure Morphine Value Share by Manufacturers in 2018
Table Key Manufacturers Morphine Price (2014-2019) (USD/Unit)
Table Morphine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Morphine Product Type
Table Date of International Manufacturers Enter into Morphine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Morphine Sales by Product (2014-2019) (K Units)
Table Global Morphine Sales Share by Product (2014-2019)
Figure Global Morphine Sales Market Share by Product (2014-2019)
Figure Global Morphine Sales Market Share by Product in 2018
Table Global Morphine Revenue by Product (2014-2019) (Million US$)
Table Global Morphine Revenue Share by Product (2014-2019)
Figure Global Morphine Revenue Market Share by Product (2014-2019)
Figure Global Morphine Revenue Market Share by Product in 2018
Table Morphine Price by Product 2014-2019 (USD/Unit)
Table Global Morphine Sales by End User (2014-2019) (K Units)
Table Global Morphine Sales Share by End User (2014-2019)
Figure Global Sales Morphine Market Share by End User (2014-2019)
Figure Global Sales Morphine Market Share by End User in 2018
Figure North America Morphine Sales Growth Rate 2014-2019 (K Units)
Figure North America Morphine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Morphine Sales by Countries (2014-2019) (K Units)
Table North America Morphine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Morphine Sales Market Share by Countries
Table North America Morphine Revenue by Countries (2014-2019) (Million US$)
Table North America Morphine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Morphine Revenue Market Share by Countries
Figure United States Morphine Sales Growth Rate (2014-2019) (K Units)
Figure United States Morphine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Morphine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Morphine Sales by Product (2014-2019) (K Units)
Table North America Morphine Sales Market Share by Product (2014-2019)
Figure 2018 North America Morphine Market Share by Product
Table North America Morphine Sales by End User (2014-2019) (K Units)
Table North America Morphine Sales Market Share by End User (2014-2019)
Figure 2018 North America Morphine Market Share by End User
Figure Europe Morphine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Morphine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Morphine Sales by Countries (2014-2019) (K Units)
Table Europe Morphine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Morphine Sales Market Share by Countries
Table Europe Morphine Revenue by Countries (2014-2019) (Million US$)
Table Europe Morphine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Morphine Revenue Market Share by Countries
Figure Germany Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Morphine Sales Growth Rate (2014-2019) (K Units)
Figure France Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Morphine Sales Growth Rate (2014-2019) (K Units)
Figure UK Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Morphine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Morphine Sales by Product (2014-2019) (K Units)
Table Europe Morphine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Morphine Market Share by Product
Table Europe Morphine Sales by End User (2014-2019) (K Units)
Table Europe Morphine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Morphine Market Share by End User
Figure Asia Pacific Morphine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Morphine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Morphine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Morphine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Morphine Sales Market Share by Countries
Table Asia Pacific Morphine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Morphine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Morphine Revenue Market Share by Countries
Figure China Morphine Sales Growth Rate (2014-2019) (K Units)
Figure China Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Morphine Sales Growth Rate (2014-2019) (K Units)
Figure India Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Morphine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Morphine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Morphine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Morphine Market Share by Product
Table Asia Pacific Morphine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Morphine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Morphine Market Share by End User
Figure Central & South America Morphine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Morphine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Morphine Sales by Countries (2014-2019) (K Units)
Table Central & South America Morphine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Morphine Sales Market Share by Countries
Table Central & South America Morphine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Morphine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Morphine Revenue Market Share by Countries
Figure Brazil Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Morphine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Morphine Sales by Product (2014-2019) (K Units)
Table Central & South America Morphine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Morphine Market Share by Product
Table Central & South America Morphine Sales by End User (2014-2019) (K Units)
Table Central & South America Morphine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Morphine Market Share by End User
Figure Middle East and Africa Morphine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Morphine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Morphine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Morphine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Morphine Sales Market Share by Countries
Table Middle East and Africa Morphine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Morphine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Morphine Revenue Market Share by Countries
Figure GCC Countries Morphine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Morphine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Morphine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Morphine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Morphine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Morphine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Morphine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Morphine Market Share by Product
Table Middle East and Africa Morphine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Morphine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Morphine Market Share by End User
Table Mallinckrodt Pharmaceuticals Company Details
Table Mallinckrodt Pharmaceuticals Morphine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mallinckrodt Pharmaceuticals Recent Development
Table Alcaliber Company Details
Table Alcaliber Morphine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alcaliber Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Morphine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Purdue Pharma Recent Development
Table Sanofi Winthrop Industrie Company Details
Table Sanofi Winthrop Industrie Morphine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Winthrop Industrie Recent Development
Table Macfarlan Smith Company Details
Table Macfarlan Smith Morphine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Macfarlan Smith Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Morphine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceutical Industries Recent Development
Table Qinghai Pharmaceutical Company Details
Table Qinghai Pharmaceutical Morphine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Qinghai Pharmaceutical Recent Development
Table Northeast Pharmaceutical Group Company Details
Table Northeast Pharmaceutical Group Morphine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Northeast Pharmaceutical Group Recent Development
Table Global Morphine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Morphine Sales Market Share Forecast by Regions 2019-2025
Table Global Morphine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Morphine Revenue Market Share Forecast by Regions 2019-2025
Table Global Morphine Sales Forecast by Product 2019-2025 (K Units)
Table Global Morphine Sales Market Share Forecast by Product 2019-2025
Table Global Morphine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Morphine Revenue Market Share Forecast by Product 2019-2025
Table Global Morphine Sales Forecast by End User 2019-2025 (K Units)
Table Global Morphine Sales Market Share Forecast by End User 2019-2025
Figure North America Morphine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Morphine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Morphine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Morphine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Morphine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Morphine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Morphine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Morphine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Morphine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Morphine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Morphine Value Chain
Table Morphine Customers List
Table Morphine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Celiac Disease Drugs Market Research Report 2012-2024
    Published: 19-Jan-2019        Price: US 1800 Onwards        Pages: 73
    The global Celiac Disease Drugs market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows:......
  • Nasal Drops Market Insights 2019, Global and Chinese Scenario
    Published: 18-Jan-2019        Price: US 3000 Onwards        Pages: 148
    Nasal Drops Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Nasal Drops industry with a focus on the Chinese market. The report provides key statistics on the market status of the Nasal Drops manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Nasal Drops market covering all......
  • Retinal Drugs Market Insights 2019, Global and Chinese Scenario
    Published: 18-Jan-2019        Price: US 3000 Onwards        Pages: 136
    Retinal Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Retinal Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Retinal Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Retinal Drugs market cove......
  • Global Cystic Fibrosis Drugs Market Research Report 2012-2024
    Published: 18-Jan-2019        Price: US 2210 Onwards        Pages: 85
    The global Cystic Fibrosis Drugs market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows:......
  • Global Muscle Relaxant Drugs Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 126
    Muscle spasticity is caused by damage to the spinal cord or brain. Nerves in the brain and spinal cord help relax the muscles during the idle state. Conditions that affect the brain or spinal cord such as multiple sclerosis, cerebral palsy, and stroke can interfere with normal muscle relaxation, leading to involuntary muscle spasms. This will impair the ability to walk, work, sleep, or just function normally. The muscles can also become excessively tense and develop overactive or overresponsive ......
  • Global Neutropenia Treatment Market Size, Status and Forecast 2019-2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 93
    Neutropenia is an abnormal condition, characterized by critically low levels of circulating neutrophils, a type of WBC found in the blood. These cells make up for the majority of circulating lymphocytes and help defend the body against infections by bacteria, viruses, and other pathogenic organisms. Decrease in the neutrophil count in blood makes a patient susceptible to infections and may even prove fatal. Therefore, the condition requires immediate prophylaxis. Novel therapies combined ......
  • Obsessive-Compulsive Disorder Treatment Market Insights 2019, Global and Chinese Scenario
    Published: 17-Jan-2019        Price: US 3000 Onwards        Pages: 145
    Obsessive-Compulsive Disorder Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Obsessive-Compulsive Disorder Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Obsessive-Compulsive Disorder Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides......
  • Global Bioengineered Protein Drugs Market Insights, Forecast to 2025
    Published: 17-Jan-2019        Price: US 3900 Onwards        Pages: 114
    Bioengineered proteins are designed as the fundamental participants in all biological processes, represent as powerful therapeutic agents and include a broad range of products such as growth factors, hormones, vaccines, monoclonal antibodies, cytokines and few others. These special drugs are gaining attention across pharmaceutical industries due to their specificity, safety, bioreactivity and success rate in treating life-threatening diseases and injuries. The global Bioengineered Protei......
  • Global DNA Vaccines Market Insights, Forecast to 2025
    Published: 17-Jan-2019        Price: US 4900 Onwards        Pages: 115
    A DNA vaccine is a small, circular DNA plasmid that encode one or more protein antigens under the control of a promoter to produce immune response against disease. DNA vaccines are basically the third generation vaccines that are specifically designed to overcome the unsought properties of conventional vaccines. The increasing vulnerability of population to infectious diseases and increasing number of antibiotics resistant pathogens have created the need for effective and low-cost vaccina......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs